About ARWR Dividend Returns
Arrowhead Pharmaceuticals, Inc. (ARWR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of ARWR over the past year?
Arrowhead Pharmaceuticals, Inc. (ARWR) delivered a return of 234.58% over the past year. Since ARWR does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in ARWR be worth today?
A $10,000 investment in Arrowhead Pharmaceuticals, Inc. one year ago would be worth $33,458 today, representing a gain of $23,458.
Q3Does ARWR pay dividends?
Arrowhead Pharmaceuticals, Inc. (ARWR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ARWR, the total return equals the price-only return.
Q4Did ARWR beat the S&P 500?
Yes, Arrowhead Pharmaceuticals, Inc. (ARWR) outperformed the S&P 500 by 219.13 percentage points over the past year. ARWR delivered a total return of 234.58%, compared to the S&P 500's 15.45%. This 219.13pp alpha means investors in ARWR earned more than a passive S&P 500 index fund.
Q5What is ARWR's worst drawdown?
Arrowhead Pharmaceuticals, Inc. (ARWR) experienced a maximum drawdown of -47.17% over the past year, declining from its peak on 2025-02-28 to its trough on 2025-04-08. The stock recovered to its prior peak by 2025-08-13. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is ARWR's long-term total return over 10, 20, or 30 years?
Arrowhead Pharmaceuticals, Inc. (ARWR) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 1522.3% (32.1% CAGR) — $10,000 would have grown to $162,231. Over 20 years: 29.1% total return (1.3% CAGR) — $10,000 → $12,912. Over 30 years: -77.8% total return (-4.9% CAGR) — $10,000 → $2,222. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was ARWR's best and worst year?
Arrowhead Pharmaceuticals, Inc.'s best calendar year was 2013 with a total return of 416.7%. Its worst year was 2001 with a total return of -75.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 492.5 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).